Gergen Mark J

CIK 00013731104 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001373110

Recent Transactions

34 trades

Exercise/Conversion
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2024-12-10−30,000→ 96,372 total
Sale
Poseida Therapeutics, Inc.
Common Stock
2024-12-10$9.46/sh−30,000→ 651,291 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Common Stock
2024-12-10$2.78/sh+30,000→ 681,291 total
Sale
Poseida Therapeutics, Inc.
Common Stock
2024-11-26$9.27/sh−30,000→ 651,291 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2024-11-26−30,000→ 126,372 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Common Stock
2024-11-26$2.78/sh+30,000→ 681,291 total
Tax Payment
Poseida Therapeutics, Inc.
Common Stock
2024-03-01$4.13/sh−34,157→ 651,291 total
Tax Payment
Poseida Therapeutics, Inc.
Common Stock
2024-02-01$3.41/sh−47,162→ 685,448 total
Award
Poseida Therapeutics, Inc.
Stock Option (Right to buy)
2024-01-02+172,600→ 172,600 total
Award
Poseida Therapeutics, Inc.
Common Stock
2024-01-02+125,000→ 732,610 total
Award
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2023-03-01+364,060→ 364,060 total
Award
Poseida Therapeutics, Inc.
Common Stock
2023-03-01+269,586→ 601,610 total
Tax Payment
Poseida Therapeutics, Inc.
Common Stock
2023-02-01$7.00/sh−31,819→ 330,314 total
Award
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2022-02-01+518,500→ 518,500 total
Award
Poseida Therapeutics, Inc.
Common Stock
2022-02-01+357,200→ 357,200 total
Award
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2021-02-04+342,000→ 342,000 total
Award
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2020-07-09+75,000→ 75,000 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2017-02-22+45,568→ 45,568 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2017-02-22+72,925→ 72,925 total
Award
Mirati Therapeutics, Inc.
Stock Option (Right to Buy)
2016-01-22+60,000→ 60,000 total
Award
AMYLIN PHARMACEUTICALS INC
Common Stock
2008-02-01$37.00/sh+182→ 3,069 total
Sale
AMYLIN PHARMACEUTICALS INC
Common Stock
2007-10-01$49.83/sh−500→ 2,937 total
Exercise/Conversion
AMYLIN PHARMACEUTICALS INC
Common Stock
2007-10-01$16.80/sh+500→ 3,437 total
Exercise/Conversion
AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
2007-10-01−500→ 19,436 total
Sale
AMYLIN PHARMACEUTICALS INC
Common Stock
2007-07-02$41.20/sh−500→ 2,937 total
Exercise/Conversion
AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
2007-07-02−500→ 22,436 total
Exercise/Conversion
AMYLIN PHARMACEUTICALS INC
Common Stock
2007-07-02$16.80/sh+500→ 3,437 total
Exercise/Conversion
AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
2007-06-01−1,000→ 22,936 total
Sale
AMYLIN PHARMACEUTICALS INC
Common Stock
2007-06-01$46.16/sh−1,000→ 2,937 total
Exercise/Conversion
AMYLIN PHARMACEUTICALS INC
Common Stock
2007-06-01$16.80/sh+1,000→ 3,937 total
Sale
AMYLIN PHARMACEUTICALS INC
Common Stock
2007-02-01$38.75/sh−500→ 2,597 total
Exercise/Conversion
AMYLIN PHARMACEUTICALS INC
Common Stock
2007-02-01$16.80/sh+500→ 3,097 total
Exercise/Conversion
AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
2007-02-01−500→ 25,936 total
Award
AMYLIN PHARMACEUTICALS INC
Common Stock
2007-01-31$36.07/sh+416→ 2,597 total

Companies

Recent Filings

Address

C/O HALOZYME THERAPEUTICS, INC. 11388 SORRENTO VALLEY ROAD

SAN DIEGO, CA, 92121

View on SEC.gov